哈尔碱盐酸盐(水合)
哈尔碱盐酸盐(水合) 性质
熔点 | 265-270°C |
---|---|
储存条件 | 2-8°C |
溶解度 | 溶于水(高达 25 mg/ml)。 |
形态 | 粉末 |
颜色 | 灰白色至淡绿色 |
Merck | 14,4616 |
稳定性 | 可在-20°下蒸馏水溶液保存长达3个月。 |
LogP | 3.173 (est) |
CAS 数据库 | 343-27-1(CAS DataBase Reference) |
EPA化学物质信息 | Harmine hydrochloride (343-27-1) |
哈尔碱盐酸盐(水合) 用途与合成方法
Target | Value |
DYRK1A
(Cell-free assay) | 33 nM |
MNB
(Cell-free assay) | 149 nM |
DYRK1B
(Cell-free assay) | 166 nM |
DYRK2
(Cell-free assay) | 1.9 μM |
Harmine inhibits tau phosphorylation by DYRK1A by selected DANDYs, with an IC 50 of 190 nM. Harmine negatively regulates homologous recombination (HR) by interfering Rad51 recruitment, resulting in severe cytotoxicity in hepatoma cells. Furthermore, NHEJ inhibitor Nu7441 markedly sensitizes Hep3B cells to the anti-proliferative effects of Harmine.
It is shown that brain water content is significantly increased in the TBI group. Treatment with Harmine significantly reduces the tissue water content at 1, 3 and 5 days, compared with the TBI group. Harmine treatment significantly reduces the escape latency at 3 and 5 days, compared with the TBI group. Post-TBI administration of Harmine significantly improves the motor function recovery of the rats at 1, 3 and 5 days following TBI, compared with the TBI group without Harmine treatment. The neuronal survival rate in the Harmine-treated group is significantly increased, compared with the TBI group. Administration of Harmine results in marked elevation in the expression of GLT-1, compared with the TBI group. The administration of Harmine significantly reduces the expression of caspase 3, compared with the TBI group.
药理药效:杀菌、止痒,抗银屑病作用,抗肿瘤作用。
安全信息
危险品标志 | Xn |
---|---|
危险类别码 | 20/21/22-40 |
安全说明 | 22-36 |
危险品运输编号 | 1544 |
WGK Germany | 3 |
RTECS号 | MG9450000 |
危险等级 | 6.1(b) |
包装类别 | III |
海关编码 | 29339900 |
哈尔碱盐酸盐(水合) 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-11-08 | S3817 | 哈尔碱盐酸盐(水合) | 343-27-1 | 25mg | 1777.43 |
2024-11-08 | S3817 | 343-27-1 | 10mM (1mL in DMSO) | 1875.51 |